The applications are for uses of under REACH regulation:

● one use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by Sanofi Pasteur

● one use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by Merck Bio development SAS and FUJIFILM Diosynth Biotechnologies UK Limited

● one use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by Swords Laboratories

● one use of 4-nonylphenol, branched and linear, ethoxylated (EC -, CAS -) by Cytiva Sweden AB

● three uses (1, 2 and 3) of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by SEBIA

● one use of 4-nonylphenol, branched and linear, ethoxylated (EC -, CAS) by SEBIA;

● two uses (1 and 2) of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by DIAGNOSTICA STAGO.

● one use of sodium chromate (EC 231-889-5, CAS 7775-11-3) by Ariston Thermo SpA;

● one use of chromium trioxide (EC 215-607-8, CAS 1333-82-0) by Tata Steel UK Ltd

● one use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by Roche Diagnostics GmbH and

● one use of 4-(1,1,3,3-tetramethylbutyl)phenol, ethoxylated (EC -, CAS -) by Nuova Ompi S.r.l. unipersonale.

Reference: https://echa.europa.eu/applications-for-authorisation-previous-consultations